BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9531606)

  • 21. Droplet Digital PCR for Minimal Residual Disease Detection in Mature Lymphoproliferative Disorders.
    Drandi D; Ferrero S; Ladetto M
    Methods Mol Biol; 2018; 1768():229-256. PubMed ID: 29717447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bcl-2/JH gene re-arrangement determined by PCR as a means to detect minimal residual disease in malignant lymphomas].
    Xiang Z; Chen Y; Li C
    Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):290-2. PubMed ID: 10920987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma.
    Ree HJ; Yang WI; Kim CW; Huh J; Lee SS; Cho EY; Ko YH; Charney D
    Hum Pathol; 2001 Sep; 32(9):954-62. PubMed ID: 11567225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the molecular staging and response in the management of follicular lymphoma patients.
    Arcaini L; Colombo N; Bernasconi P; Calatroni S; Passamonti F; Orlandi E; Bonfichi M; Burcheri S; Porta MD; Rumi E; Montanari F; Algarotti A; Pascutto C; Lazzarino M
    Leuk Lymphoma; 2006 Jun; 47(6):1018-22. PubMed ID: 16840191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does MRD have a role in the management of iNHL?
    Giudice ID; Starza ID; Foà R
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):320-330. PubMed ID: 34889425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic and prognostic value of BCL2 rearrangement in 53 patients with follicular lymphoma presenting as primary skin lesions.
    Pham-Ledard A; Cowppli-Bony A; Doussau A; Prochazkova-Carlotti M; Laharanne E; Jouary T; Belaud-Rotureau MA; Vergier B; Merlio JP; Beylot-Barry M
    Am J Clin Pathol; 2015 Mar; 143(3):362-73. PubMed ID: 25696794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Translocation t(14;18)/IGH-BCL2 in gastrointestinal follicular lymphoma: correlation with clinicopathologic features in 48 patients.
    Yanai S; Nakamura S; Takeshita M; Fujita K; Hirahashi M; Kawasaki K; Kurahara K; Sakai Y; Matsumoto T
    Cancer; 2011 Jun; 117(11):2467-77. PubMed ID: 24048795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Minimal residual disease in follicular and mantle cell lymphoma. Detection using quantitative molecular monitoring of circulating lymphoma cells].
    Schüler F; Hirt C; Dölken L; Krüger W; Dölken G
    Dtsch Med Wochenschr; 2005 Sep; 130(38):2130-4. PubMed ID: 16172952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapy.
    Maeshima AM; Taniguchi H; Nomoto J; Miyamoto K; Fukuhara S; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
    Hum Pathol; 2013 Nov; 44(11):2529-35. PubMed ID: 23916290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma.
    Galimberti S; Marasca R; Caracciolo F; Fazzi R; Papineschi F; Benedetti E; Guerrini F; Morabito F; Oliva E; Di Renzo N; Federico M; Petrini M; Torelli G;
    Bone Marrow Transplant; 2002 Apr; 29(7):581-7. PubMed ID: 11979307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective study of patients with follicular lymphoma (FL): identification of in situ FL or FL-like B cells of uncertain significance in lymph nodes resected at the time of previous surgery for carcinomas.
    Morita K; Nakamine H; Nakai T; Takano M; Takeda M; Enomoto Y; Yoshii Y; Kanno M; Ohbayashi C
    J Clin Pathol; 2015 Jul; 68(7):541-6. PubMed ID: 25862812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC/BCL2 double hit lymphoma.
    Li S; Saksena A; Desai P; Xu J; Zuo Z; Lin P; Tang G; Yin CC; Seegmiller A; Jorgensen JL; Miranda RN; Reddy NM; Bueso-Ramos C; Medeiros LJ
    Oncotarget; 2016 Jun; 7(25):38122-38132. PubMed ID: 27203548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model.
    Romaguera JE; McLaughlin P; North L; Dixon D; Silvermintz KB; Garnsey LA; Velasquez WS; Hagemeister FB; Cabanillas F
    J Clin Oncol; 1991 May; 9(5):762-9. PubMed ID: 1707956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative PCR of bone marrow BCL2/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma.
    Rambaldi A; Carlotti E; Oldani E; Della Starza I; Baccarani M; Cortelazzo S; Lauria F; Arcaini L; Morra E; Pulsoni A; Rigacci L; Rupolo M; Zaja F; Zinzani PL; Barbui T; Foa R
    Blood; 2005 May; 105(9):3428-33. PubMed ID: 15637137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
    Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
    Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphoid follicle colonization by Bcl-2(bright+)CD10(+) B-cells ("follicular lymphoma in situ") at nodal and extranodal sites can be a manifestation of follicular homing of lymphoma.
    Lee JC; Hoehn D; Schecter J; Murty VV; Mansukhani MM; Alobeid B; Bhagat G
    Hum Pathol; 2013 Jul; 44(7):1328-40. PubMed ID: 23363648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Follicular non-Hodgkin lymphomas and minimal residual disease].
    Bruno S
    Medicina (B Aires); 2000; 60 Suppl 2():77-82. PubMed ID: 11188937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature.
    Miao Y; Hu S; Lu X; Li S; Wang W; Medeiros LJ; Lin P
    Hum Pathol; 2016 Dec; 58():72-77. PubMed ID: 27544800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting.
    Corradini P; Astolfi M; Cherasco C; Ladetto M; Voena C; Caracciolo D; Pileri A; Tarella C
    Blood; 1997 Jan; 89(2):724-31. PubMed ID: 9002976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic and predictive significance of the bcl-2/IgH translocation in malignant follicular lymphomas.
    Georgescu A; Stoicea M; Comănescu M; Dobrea C; Andrei F; Neagu M; Cionca F; Ciobanu A; Lupu A; Ardeleanu C
    Rom J Morphol Embryol; 2010; 51(4):687-91. PubMed ID: 21103627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.